$1.235
-0.015 (-1.20%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
MTNB-Prognose durch Analyse ähnlicher Charts
Alphio's MTNB stock price prediction model matches the current Matinas BioPharma Holdings Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.26 (+1.99%). The 1-week path is $1.34 (+7.87%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Soll ich Matinas BioPharma Holdings Inc-Aktien kaufen?
Matinas BioPharma Holdings Inc is not a good buy right now. The current price is $1.25, with an RSI of 25.709 indicating oversold conditions, but the company has reported a staggering year-to-date change of -86.56% and a negative forward P/E ratio of 0, reflecting a lack of profitability and growth potential. Additionally, the company faces delisting risk from the NYSE due to insufficient shareholder equity, which is currently at $1.8 million, below the required $2 million. This financial instability poses a significant risk for investors.
MTNB schloss am Monday bei $1.24, nachdem der Kurs -1.20% fallen
Matinas BioPharma Holdings Inc (MTNB) last closed at $1.24, losing -0.80%. These facts feed the 1-day and 1-week MTNB price prediction above.
Analystenkonsens
Matinas BioPharma Holdings Inc (MTNB): 3 Kaufen, 0 Halten, 0 Verkaufen. Ausblick: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Prognose-Treiber
Die Prognose-Treiber von Matinas BioPharma Holdings Inc (MTNB) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Ähnliche Chartmuster
Aktien, deren jüngster Kursverlauf MTNB am ähnlichsten ist, sortiert nach Ähnlichkeit.
Saisonalitätsanalyse für MTNB
Historically the probability of a positive November return for MTNB is 42.22%. June offers the highest probability of a positive month at 65.00%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-Jahres-Kursprojektionen für MTNB
| Monat | Tiefstkurs | Ø-Kurs | Höchstkurs | Potenzieller ROI |
|---|---|---|---|---|
| Nov 2026 | $0.84 | $0.86 | $1.08 | -30.90% |
| Dec 2026 | $0.95 | $1.00 | $1.12 | -19.18% |
Für 2026 wird für Matinas BioPharma Holdings Inc (MTNB) eine Spanne von $0.84 bis $1.12 projiziert.
Monatsprognose 2026 für Matinas BioPharma Holdings Inc
Im Nov 2026 wird für Matinas BioPharma Holdings Inc ein Durchschnitt von $0.86 erwartet, mit einem Tief von $0.84 und einem Hoch von $1.08.
Im Dec 2026 wird für Matinas BioPharma Holdings Inc ein Durchschnitt von $1.00 erwartet, mit einem Tief von $0.95 und einem Hoch von $1.12.
Ähnliche Artikel
- CPI Report and the Stock Market: How to Read October 2026 Inflation Data Before the Fed DecidesOctober 2026 CPI lands Nov 10 with no year-over-year number and Fed hike odds near 80%. Learn how to read CPI, which stocks react, and how to plan for it.
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.